The biofabricated liver: A joint effort for personalized medicine and drug development

Description

Dr. Bart Spee and his colleagues are the first scientists to combine the organoid culturing technique with 3D-bioprinting. Their research aims to develop biofabricated liver constructs to predict hepatoxicity and drug treatment efficacy. Besides being pioneers in combining these specific techniques, they also provide a great example of team effort: multiple organizations all play their part in providing expertise in this multidisciplinary research project. In January 2016, the 3Rs-Centre ULS already published an interview with Dr. Spee about the development of this model. Now, exactly 3 years later, we return to ask him about the progress that has been made.
What has been improved and which challenges still lie ahead?

Period	Feb 2019
Degree of Recognition	International